The object of this study is to provide information on the natural course of rheumatic heart disease in the third, fourth, and fifth decades of life. It is concerned with 757 out of 1,042 children under observation during the years 1916 to 1956 who reached the age of 20 or more years. The major manifestations of rheumatic fever experienced by these patients from the onset of the disease is related to the degree of residual cardiac damage. Survival to successive ages Was analyzed with respect to sex, type of valvular lesion, and degree of cardiac enlargement.
BASIC data on the natural course of a chronic disease are essential for evaluation of the effect of therapeutic procedures. In 1947 we presented the mortality experience of a group of 1,042 children who had been under medical supervision during the years 1916 to 1947.' Another 10 years have elapsed, providing information on the natural course of rheumatic heart disease in the third, fourth, and fifth decades of life. This report is concerned with 757 of those patients who have reached the age of 20 years or more. Prognosis will be considered in terms of the major manifestations of rheumatic fever experienced during the course of the disease and the degree of residual cardiac damage." 2 Survivorship will be analyzed to successive ages, specific for sex, type of valvular lesion, and degree of cardiac enlargement.
In order to assess survivorship or mortality risks for any of these groups, due account must tion of patients for cardiac surgery or other therapeutic procedures.
In interpreting the data it must be remenmbered that our patients represent a group that sought medical care in childhood and have been followed without further selection into adult life. They are not therefore comparable to a group of adults inl whom cardiovascular disease is discovered onl examinatiois or to those seeking medical care for cardiopulmonary symptoms.
Sufficient data have accumulated in the past 8 years to indicate that immediate surgical mortality has decreased withl experience, both in surgical technics and inl selection of patients, and the majority of published studies indicate an improvement in functional cardiac status5-8 but beyond this we have no real assessment of results. The difficulty in judging the surgical experience as reported in the literature is that survivorship is usually given in terms of the direct calculation of the proportion of patients in any series who survived, without any account being taken of the variable length of follow-up. This index cannot be interpreted even in a descriptive sense.
It is hoped that the present study will give further perspective on the disease and furnish some guides in the selectiomi of patients for surgical intervention as well as for evaluating its effect on longevity.
tion since 1916, the records of 757 patients who reached the age of 20 or more years were reviewed.' Of these, 73, or 10 per cent, were lost at various points in the follow-up; 90 per cent were observed until death or the end of the study on January 1, 1956 .
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METHODOLOGY
Analysis of long-term follow-up observations is best expressed in terms of a life table or its equivalent. The requisites for deriving a life table include a specified starting point and the distribution according to time from the starting point of the number of individuals alive and under study, the number lost from observation, and the number of individuals who died. In this study, patients had as their starting point 20 years of age. In analysing survivorship, the information furnished by each individual in the study must be included for the entire period of observation. The assumption in handling the "lost" patients is that subsequent to their last observation they are dying off at the same rate as those remaining under follow-up. It is important to note that the 73 patients who were lost from observation at various points in our follow-up were slightly more favorable in their diagnostic classification than those remaining under follow-up. It seems unlikely, therefore, that any appreciable number were lost because they died or that the assumption as to subsequent mortality is seriously in error.
As in our previous analysis, we have presented both the average annual death rate for 5-year age groups and the probability of dying between the birthdays that mark the beginning and close of each 5-year period for all cases. The latter description permits the calculation of a survivorship table from the age of 20 years to the latest age to which the patients have been followed. We have presented this survivorship only to the age of 45 years, since, up to the present time, only a small number have attained later ages and the sampling errors therefore became substantial.
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stant in about two thirds of these patients, and regressed in about one third. The regression of murmurs probably accounts for the reported incidence of isolated aortic insufficiency, and presumably for "pure mitral stenosis." In the majority of these patients there was cardiac chamber enlargement of "moderate" degree and in only one fifth was there "marked" enlargement. In The frequency of the observed regression of systolic and diastolic murmurs during the clinical course needs emphasis. That absence of murmurs does not exclude persistence of valvular pathology has been demonstrated at postmortem and more recently during surgical exploration. The degree of residual cardiac damage and the constancy of murmurs paralleled the incidence of acute carditis. It is noteworthy that there was no significant difference in the incidence of attacks of polyarthritis or chorea in patients with mitral insufficiency or mitral stenosis. New murmurs or increasing cardiac chamber enlargement was rarely observed in the absence of rheumatic activity. Cardiac chamber enlargement did not appear to increase with time.
In 9 of the 53 patients whose death was attributed to cardiac causes, active carditis was demonstrated clinically or pathologically. The majority of the 8 deaths due to bacterial endocarditis occurred before the era of antibiotic therapy. Six patients who developed bacterial endocarditis during the past 6 years and were treated, are alive and asymptomatic. A more critical analysis of the morbidity of the majority of these patients, as well as consideration of factors contributing to the terminal event, will be presented in a subsequent report. ' Figure  3B shows that the survival curve for these patients is significantly better than that which obtained for patients with mitral stenosis and insufficiency ( fig. 3C) , and for combined aortic and mitral lesions ( fig. 3D) significantly less than for patients with combined aortic and mitral lesions ( fig. 3B-D) .
For the 96 patients with combined aortic and mitral lesions the over-all average annual mortality rate is 29 per 1,000, based on a total of 1,273 person-years. Figure 3D indicates that the survival curve drops precipitously after 30 years of age; 78 per cent of these patients survived to age 30, 65 per cent to 35, and 49 per cent to the age of 40 years.
A comparison of mortality according to heart size (table 5) reveals an over-all average annual mortality rate of 3.5 per 1,000 for a total of 7,736 person-years for 632 patients having moderate enlargement of the heart, compared to 31.6 per 1,000 for a total of 1,612 person-years in 125 patients with marked enlargement. Survival rates are significantly lower for patients with marked cardiac enlargement than for those with moderate enlargement, as shown in figure 4A . In average annual mortality rate of 4.1 per 1,000 for moderate enlargement compared to 28.8 per 1,000 for patients with marked cardiac enlargement.
For patients with combined aortic lesions and moderate enlargement of the heart, the over-all average annual mortality rate was 7.6 per 1,000 compared to 34.6 for patients with marked enlargement.
Although the total person-years of observation for some of the subgroups is rather small, the consistency of the comparisons and the trend in survival curves appear to indicate that degree of cardiac enlargement is an important factor in influencing survivorship ( fig. 4B, C,  D) . It is of interest that insurance mortality investigations of physical impairment also coneluded that the degree of cardiac enilarlgemiienit affected survivorship adversely.'5 Comment Interpretation of the data presented on mortality and survivorship for patients with rheumatic heart disease must take into account the representativeness of the sample subject to analysis.
Unlike the previous study on longevity in rheumatic fever' where children were included at, onset of the disease at various ages, this analysis concerns only those children who reached the age of 20 years. All the patients were kept under continuous medical supervision as part of a long-term study of the natural history of rheumatic heart disease. As stated earlier, they are not comparable to a series of patients seeking medical attention because of cardiopulmonary symptoms, and any estimate of mortality risk based on such a symptomatic group would greatly exaggerate the true mortality for persons having a history of rheumatic fever.
When the results of this study are compared with those of the previous one,1 it is seen that the over-all average mortality rate in the third, fourth, and fifth decades is 8.3 
It is significant that for the 391 patients with mitral insufficiency and moderate cardiac enlargement the survival curve, after 20 years of age, followed closely that of the general population.
The importance of degree of cardiac chamber enlargement is indicated by the low survival rates among patients with marked cardiac enlargement. The morbidity experienced by a majority of these patients will be considered in a subsequent study.'6 DISCUSSION Prognosis for patients with rheumatic heart disease who reached the age of 20 years is obviously dependent on the degree of residual cardiac damage sustained during the earlier years. It is significant that in about 50 per cent of the patients, residual cardiac damage was characterized by mitral insufficiency and moderate cardiac enlargement. In two thirds of these patients the auscultatory murmurs regressed and cardiac chamber enlargement would not have been recognized on physical examination or by the usual radiographic examination limited to the posteroanterior view. These patients are probably representative of those individuals who have had rheumatic fever and are considered to be without clinical evidence of heart disease. It is important to note that when patients in this study were noted to have regression of characteristic murmurs with persistent cardiac chamber enlargement, the valvular diagnosis was not changed. It is probable that patients who are considered to have "pure" mitral stenosis or isolated aortic insufficiency may have had regression of the characteristic murmurs of mitral lesions.
The significance of the relation of the extent of residual cardiac damage to the severity of carditis is illustrated by the relative increased incidence of acute carditis among patients with mitral stenosis aiid combined aortic lesions and markedly enlarged hearts. It is perhaps of some significance that among these patients, so-called "delayed" appearance of mitral stenosis was rarely observed in the absence of clinical evidence of rheumatic carditis. The diagnosis of mitral stenosis was recorded in the majority of patients withini 1 to 2 years of an observed attack of carditis.
In practically all of the patients the anatomic diagnosis was established by the age of 20 years. It is apparent therefore that it is during childhood that cardiac damage must be prevented. Our recent observations,' demonstrating that early adequate short-term hormone therapy in active carditis will result in diminished residual cardiac damage, offer justification for the prediction that the survival rate for patients so treated, reaching the age of 20, will approximate that which is observed for the 50 per cent of patients with minimal cardiac damage.
At the present time it is not possible, from published data, to assess the effect of surgical intervention on longevity. However, if it wsere found that survival rates were favorably affected, particularly among patients with marked cardiac enlargement and combined valvular lesions, earlier surgical intervention may be indicated as suggested by many surgeons. Whether an even more favorable survivorship would result for patients with valvular lesions and moderate cardiac enlargement following surgical intervention must await controlled studies.
It must again be emphasized that the survival rates for patients with rheumatic heart disease as presented refers to a series of patients with rheumatic heart disease who were kept under supervision from childhood. Of significance is the fact that for those who had mitral insufficiency with moderate cardiac enlargement, comprising about one half of the total group, the survival rate followed closely that of the general population. In a series of adult patients who seek medical attention because of cardiopulmonary symptoms, survivorship would not be expected to be as favorable.
SUMMARY
The observed natural history of rheumatic heart disease is presented for the 757 out of 1,042 rheumatic children who reached the age of 20 The survival curve for the entire group of patients who reached the age of 20 showed that an estimated 82 per cent of them would reach the age of 43 as compared with 95 per cent in the general population. There was no evidence of a sex difference in survivorship. The survival curve for patients with mitral insufficieiicy followed closely that of the general population, while for patients with mitral stenosis and insufficiency there was a decline after about 33 years of age, which is greater than for mitral insufficiency alone but less than for combined aortic and mitral lesions. Only about one half of this latter group who reached the age of (20 survived to the age of 40. The over all average mortality rate for moderate enlargement was 3.5 per 1,000 compared to 31 per 1,000 for marked enlargement. The survival curves according to degree of heart enlargement are markedly different. Of the persons who survived to the age of 20, 93 per cent survived to the age of 40 when the heart enlargement was "moderate" while only 40 per cent survived to 40 when the heart enlargement at age 20 was "marked." When valvular lesions and heart enlargement are considered simultaneously, heart size appears to be the more important factor in relation to survivorship. SUMMARIO 
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